A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.61 HKD -4.75% Market Closed
Market Cap: 58B HKD
Have any thoughts about
Alibaba Health Information Technology Ltd?
Write Note

Gross Margin
Alibaba Health Information Technology Ltd

23.2%
Current
21%
Average
32.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
23.2%
=
Gross Profit
6.6B
/
Revenue
28.3B

Gross Margin Across Competitors

Country HK
Market Cap 58B HKD
Gross Margin
23%
Country US
Market Cap 2.1T USD
Gross Margin
48%
Country ZA
Market Cap 838.5B Zac
Gross Margin
38%
Country CN
Market Cap 205B USD
Gross Margin
38%
Country CN
Market Cap 144.6B USD
Gross Margin
62%
Country CN
Market Cap 916.6B HKD
Gross Margin
37%
Country AR
Market Cap 99.3B USD
Gross Margin
46%
Country UY
Market Cap 2T MXN
Gross Margin
46%
Country NL
Market Cap 92.8B EUR
Gross Margin
41%
Country US
Market Cap 71.9B USD
Gross Margin
48%
Country CN
Market Cap 399.8B HKD
Gross Margin
16%
No Stocks Found

Alibaba Health Information Technology Ltd
Glance View

Market Cap
58B HKD
Industry
Retail

Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for millions of individuals across China. As an investor, one cannot overlook Alibaba Health's strategic position in the booming digital healthcare sector fueled by an aging population and rising health awareness among Chinese consumers. The company has established significant partnerships with hospitals, pharmacies, and other healthcare stakeholders, facilitating integration across the health system. With its robust technological infrastructure and the backing of the Alibaba Group, Alibaba Health is well-equipped to capitalize on emerging trends and regulatory shifts in China's healthcare environment. Their ambitious growth strategy and commitment to innovation position them as a potential long-term investment, promising not only strong financial returns but also a meaningful impact on the lives of individuals seeking quality healthcare services.

Intrinsic Value
2.69 HKD
Overvaluation 26%
Intrinsic Value
Price
A

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
23.2%
=
Gross Profit
6.6B
/
Revenue
28.3B
What is the Gross Margin of Alibaba Health Information Technology Ltd?

Based on Alibaba Health Information Technology Ltd's most recent financial statements, the company has Gross Margin of 23.2%.